Bandaram Pharma Packtech Faces Financial Stability Concerns Amid Technical Outlook Shift
Bandaram Pharma Packtech, a microcap in the Medical Equipment sector, has experienced a recent evaluation adjustment indicating a shift in its technical outlook. While maintaining a moderate Return on Equity, the company faces challenges with a high Debt to Equity ratio and flat financial performance in the latest quarter.
Bandaram Pharma Packtech, a microcap player in the Medical Equipment/Supplies/Accessories industry, has recently undergone an evaluation adjustment that reflects a shift in its technical outlook. The company's technical indicators have shown a transition, with various metrics suggesting a more cautious stance. Key financial metrics indicate that Bandaram Pharma has maintained a Return on Equity of 8.09%, which points to a moderate level of profitability relative to shareholders' funds. However, the company is characterized by a high Debt to Equity ratio of 2.78 times, raising concerns about its long-term financial stability.
Despite a notable return of 20.21% over the past year, the company has faced challenges, including flat financial performance in the latest quarter and a reported EPS of Rs -0.01. The technical landscape has shifted, with indicators such as MACD and Bollinger Bands reflecting a bearish sentiment.
As the market continues to evolve, Bandaram Pharma Packtech's recent evaluation adjustment underscores the complexities of its financial health and market position.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
